APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE
Dormant
DIN Number
02416255
Drug Class
Human
Market Date
Dec 28, 2015
Company
HC
Apotex Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02416255
AIG Number0345541001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR04 ZIDOVUDINE, LAMIVUDINE AND ABACAVIR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification
ACTIVE INGREDIENTS (3)
ABACAVIR (ABACAVIR SULFATE)Active
Strength: 300 MG
Monograph: ABACAVIR (ABACAVIR SULFATE)
LAMIVUDINEActive
Strength: 150 MG
Monograph: LAMIVUDINE
ZIDOVUDINEActive
Strength: 300 MG
Monograph: ZIDOVUDINE